Phase I Trial of Aflibercept (VEGF Trap) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Glioma

Trial Profile

Phase I Trial of Aflibercept (VEGF Trap) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Glioma

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Jul 2014

At a glance

  • Drugs Aflibercept (Primary) ; Temozolomide
  • Indications Anaplastic astrocytoma; Glioblastoma; Glioma
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 21 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 25 May 2012 Actual patinent number is 60 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top